NYSE:ABT

Abbott Laboratories News Headlines

$120.98
-0.11 (-0.09 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$120.40
$121.42
50-Day Range
$105.79
$121.09
52-Week Range
$98.67
$128.54
Volume4.68 million shs
Average Volume4.50 million shs
Market Capitalization$214.96 billion
P/E Ratio34.08
Dividend Yield1.49%
Beta0.68

Abbott Laboratories (NYSE ABT) News Headlines Today

SourceHeadline
Abbott Laboratories (NYSE:ABT) Given New $136.00 Price Target at Morgan StanleyAbbott Laboratories (NYSE:ABT) Given New $136.00 Price Target at Morgan Stanley
marketbeat.com - July 23 at 10:07 AM
Abbott Laboratories Proves Its Worth Again Abbott Laboratories Proves Its Worth Again 
marketbeat.com - July 22 at 9:19 AM
The Top 3 Healthcare Stocks to Buy in July (ABT)The Top 3 Healthcare Stocks to Buy in July (ABT)
marketbeat.com - July 6 at 7:23 PM
This Safe 5-Stock Healthcare Portfolio Yields 5.5%This Safe 5-Stock Healthcare Portfolio Yields 5.5%
marketbeat.com - July 1 at 10:01 PM
Abbott Launches Latest Insertable Cardiac Monitor For Irregular Heart RhythmsAbbott Launches Latest Insertable Cardiac Monitor For Irregular Heart Rhythms
feeds.benzinga.com - July 30 at 1:31 PM
Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On CapitalAbbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital
finance.yahoo.com - July 30 at 8:43 AM
Reviewing Teva Pharmaceutical Industries (NYSE:TEVA) and Abbott Laboratories (NYSE:ABT)Reviewing Teva Pharmaceutical Industries (NYSE:TEVA) and Abbott Laboratories (NYSE:ABT)
americanbankingnews.com - July 29 at 11:21 AM
New Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical LimitationsNew Study: Half of Americans Living with Diabetes May be Consuming Less Than the Recommended Amount of Protein, which is Associated with Greater Physical Limitations
finance.yahoo.com - July 29 at 9:26 AM
Abbott Laboratories (NYSE:ABT) Releases FY 2021 Earnings GuidanceAbbott Laboratories (NYSE:ABT) Releases FY 2021 Earnings Guidance
americanbankingnews.com - July 29 at 7:41 AM
Analyzing Abbott Laboratoriess Unusual Options ActivityAnalyzing Abbott Laboratories's Unusual Options Activity
benzinga.com - July 28 at 2:10 PM
The Bullish Case for Abbott LaboratoriesThe Bullish Case for Abbott Laboratories
stocknews.com - July 28 at 2:10 PM
William Blair Comments on Abbott Laboratories Q3 2021 Earnings (NYSE:ABT)William Blair Comments on Abbott Laboratories' Q3 2021 Earnings (NYSE:ABT)
americanbankingnews.com - July 26 at 2:34 AM
SVB Leerink Analysts Reduce Earnings Estimates for Abbott Laboratories (NYSE:ABT)SVB Leerink Analysts Reduce Earnings Estimates for Abbott Laboratories (NYSE:ABT)
americanbankingnews.com - July 26 at 2:34 AM
Abbott Laboratories Is Likely To Melt Up Into 2022Abbott Laboratories Is Likely To Melt Up Into 2022
seekingalpha.com - July 25 at 2:21 PM
Abbott’s Q2 Earnings Rise 105%, Beat EstimatesAbbott’s Q2 Earnings Rise 105%, Beat Estimates
nasdaq.com - July 23 at 8:09 PM
Morgan Stanley Raises Abbott Laboratories (NYSE:ABT) Price Target to $136.00Morgan Stanley Raises Abbott Laboratories (NYSE:ABT) Price Target to $136.00
americanbankingnews.com - July 23 at 4:18 PM
Credit Suisse Group Boosts Abbott Laboratories (NYSE:ABT) Price Target to $130.00Credit Suisse Group Boosts Abbott Laboratories (NYSE:ABT) Price Target to $130.00
americanbankingnews.com - July 23 at 4:18 PM
Abbott Laboratories (NYSE:ABT) PT Raised to $128.00Abbott Laboratories (NYSE:ABT) PT Raised to $128.00
americanbankingnews.com - July 23 at 10:41 AM
Abbott (ABT) Surpasses Q2 Earnings and Revenue EstimatesAbbott (ABT) Surpasses Q2 Earnings and Revenue Estimates
markets.businessinsider.com - July 23 at 10:07 AM
Abbott reports quarterly sales, profit gains despite lower Covid-19 testing demandAbbott reports quarterly sales, profit gains despite lower Covid-19 testing demand
bizjournals.com - July 22 at 1:17 PM
Abbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales DropAbbott (ABT) Q2 Earnings Beat, Molecular Diagnostic Sales Drop
finance.yahoo.com - July 22 at 1:17 PM
Abbott Hits The Skids As Covid Testing Demand Falls Off Despite Quarterly BeatAbbott Hits The Skids As Covid Testing Demand Falls Off Despite Quarterly Beat
finance.yahoo.com - July 22 at 1:17 PM
Abbott Laboratories (ABT) Q2 2021 Earnings Call TranscriptAbbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
finance.yahoo.com - July 22 at 1:17 PM
Abbott Laboratories (NYSE:ABT) Issues FY21 Earnings GuidanceAbbott Laboratories (NYSE:ABT) Issues FY21 Earnings Guidance
americanbankingnews.com - July 22 at 8:38 AM
Abbott Laboratories Maintains FY21 Outlook - Quick FactsAbbott Laboratories Maintains FY21 Outlook - Quick Facts
markets.businessinsider.com - July 22 at 8:16 AM
Abbott Laboratories Q2 Income AdvancesAbbott Laboratories Q2 Income Advances
markets.businessinsider.com - July 22 at 8:16 AM
Abbott Laboratories: Q2 Earnings InsightsAbbott Laboratories: Q2 Earnings Insights
benzinga.com - July 22 at 8:16 AM
Abbott profit more than doubles as medical device sales reboundAbbott profit more than doubles as medical device sales rebound
in.finance.yahoo.com - July 22 at 8:16 AM
UPDATE 1-Abbott profit more than doubles as medical device sales reboundUPDATE 1-Abbott profit more than doubles as medical device sales rebound
finance.yahoo.com - July 22 at 8:16 AM
Abbott Labs stock gains after profit more than doubles, sales rise above expectationsAbbott Labs stock gains after profit more than doubles, sales rise above expectations
finance.yahoo.com - July 22 at 8:16 AM
How Important Is Re-Investing Dividends? A Five-Year Analysis For Abbott LaboratoriesHow Important Is Re-Investing Dividends? A Five-Year Analysis For Abbott Laboratories
benzinga.com - July 20 at 2:08 PM
A Look Into Abbott Laboratories Price Over EarningsA Look Into Abbott Laboratories Price Over Earnings
benzinga.com - July 20 at 2:08 PM
SVB Leerink Increases Abbott Laboratories (NYSE:ABT) Price Target to $128.00SVB Leerink Increases Abbott Laboratories (NYSE:ABT) Price Target to $128.00
americanbankingnews.com - July 20 at 2:04 PM
Lower COVID-19 Testing Demand to Drag Abbott (ABT) Q2 EarningsLower COVID-19 Testing Demand to Drag Abbott (ABT) Q2 Earnings
finance.yahoo.com - July 16 at 2:14 PM
Fleeing Texas should end Democrats court fight over Abbott funding veto, GOP arguesFleeing Texas should end Democrats' court fight over Abbott funding veto, GOP argues
msn.com - July 15 at 11:01 PM
Zacks: Analysts Anticipate Abbott Laboratories (NYSE:ABT) Will Post Earnings of $1.01 Per ShareZacks: Analysts Anticipate Abbott Laboratories (NYSE:ABT) Will Post Earnings of $1.01 Per Share
americanbankingnews.com - July 15 at 1:14 PM
Delivering Long-Term Impact: Abbotts 2020 Sustainability ReportDelivering Long-Term Impact: Abbott's 2020 Sustainability Report
finance.yahoo.com - July 15 at 1:01 PM
St. Jude Medical settles with Justice Department, will pay $27 millionSt. Jude Medical settles with Justice Department, will pay $27 million
bizjournals.com - July 13 at 11:18 PM
Why Worry With Dividends? Their Five-Year Reinvested Value for Abbott LaboratoriesWhy Worry With Dividends? Their Five-Year Reinvested Value for Abbott Laboratories
benzinga.com - July 13 at 12:15 PM
Ex-Dividend Reminder: Abbott Laboratories, AbbVie and BankUnitedEx-Dividend Reminder: Abbott Laboratories, AbbVie and BankUnited
nasdaq.com - July 12 at 2:13 PM
Abbott Lays Off Around 400 Employees As COVID-19 Test Demand EvaporatesAbbott Lays Off Around 400 Employees As COVID-19 Test Demand Evaporates
finance.yahoo.com - July 9 at 6:09 PM
Abbott Laboratories (NYSE:ABT) Looks Like A Good Stock, And Its Going Ex-Dividend SoonAbbott Laboratories (NYSE:ABT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
nasdaq.com - July 9 at 7:55 AM
St. Jude Medical to pay $27 mln to settle allegations over heart devicesSt. Jude Medical to pay $27 mln to settle allegations over heart devices
reuters.com - July 8 at 5:52 PM
Heres What Abbott Laboratories (NYSE:ABT) Shareholder Ownership Structure Looks LikeHere's What Abbott Laboratories' (NYSE:ABT) Shareholder Ownership Structure Looks Like
nasdaq.com - July 8 at 7:51 AM
Abbotts (ABT) DAPT for High Bleeding Risk Gets FDA ApprovalAbbott's (ABT) DAPT for High Bleeding Risk Gets FDA Approval
finance.yahoo.com - July 6 at 10:06 AM
Could The Abbott Laboratories (NYSE:ABT) Ownership Structure Tell Us Something Useful?Could The Abbott Laboratories (NYSE:ABT) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - July 4 at 9:42 AM
August 13th Options Now Available For Abbott Laboratories (ABT)August 13th Options Now Available For Abbott Laboratories (ABT)
nasdaq.com - July 1 at 3:33 PM
Abbotts XIENCE Stent Receives FDA Approval For High Bleeding Risk PatientsAbbott's XIENCE Stent Receives FDA Approval For High Bleeding Risk Patients
markets.businessinsider.com - June 30 at 1:00 PM
Abbotts XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk PatientsAbbott's XIENCE Stent Receives FDA Approval for Shortest Blood Thinner Course for High Bleeding Risk Patients
finance.yahoo.com - June 30 at 1:00 PM
Abbott (ABT) Reports Late-Breaking Data on FreeStyle LibreAbbott (ABT) Reports Late-Breaking Data on FreeStyle Libre
finance.yahoo.com - June 30 at 1:00 PM
Abbott (ABT) CE-Marked Panbio Test Now Widely Offered in EuropeAbbott (ABT) CE-Marked Panbio Test Now Widely Offered in Europe
finance.yahoo.com - June 30 at 1:00 PM
Forget AMC: Here Are 2 Better Post-Pandemic StocksForget AMC: Here Are 2 Better Post-Pandemic Stocks
finance.yahoo.com - June 30 at 7:59 AM
ABT Makes Bullish Cross Above Critical Moving AverageABT Makes Bullish Cross Above Critical Moving Average
nasdaq.com - June 28 at 7:00 PM
Bear of the Day: Abbott (ABT)Bear of the Day: Abbott (ABT)
markets.businessinsider.com - June 26 at 1:35 PM
This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.